Divide and conquer: using patient-derived tumour organoids to dissect intra-tumour immune heterogeneity of non-small cell lung cancer

Project Information

TxImmuneOrganoids

Grant agreement ID: 101024529

DOI

10.3030/101024529

Project terminated on 31 December 2022

EC signature date 30 March 2021

Start date 1 August 2021

End date 31 July 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 224 933,76

EU contribution

€ 224 933,76

Coordinated by

THE FRANCIS CRICK INSTITUTE LIMITED
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

The effects of clonal heterogeneity on cancer immunosurveillance

Author(s): Dijkstra KK, Wu Y, Swanton C.
Published in: Annual Review of Cancer Biology, Issue 7, 2023, Page(s) Final publication date: April 7 2023, ISSN 2472-3428
Publisher: Annual Reviews
DOI: 10.1146/annurev-cancerbio-061521-101910

Open questions in human lung organoid research

Author(s): Hughes T, Dijkstra KK, Rawlins EL, Hynds R.
Published in: Frontiers in Pharmacology, Issue 13, 2023, Page(s) 1083017, ISSN 1663-9812
Publisher: Frontiers Media S.A.
DOI: 10.3389/fphar.2022.1083017